Regenxbio (RGNX) Operating Income Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Operating Income Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Regenxbio | 506.45 Mn | 276.38 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.44% |
| Sep 30, 2025 | -41.92% |
| Jun 30, 2025 | -8.63% |
| Mar 31, 2025 | 18.35% |
| Dec 31, 2024 | -4.96% |
| Sep 30, 2024 | -11.58% |
| Jun 30, 2024 | -8.73% |
| Mar 31, 2024 | -12.21% |
| Dec 31, 2023 | -94.84% |
| Sep 30, 2023 | -23.38% |
| Jun 30, 2023 | -68.33% |
| Mar 31, 2023 | -21.51% |
| Dec 31, 2022 | -28.33% |
| Sep 30, 2022 | -27.23% |
| Jun 30, 2022 | -32.95% |
| Mar 31, 2022 | -25.56% |
| Dec 31, 2021 | 76.89% |
| Sep 30, 2021 | -25.17% |
| Jun 30, 2021 | -28.42% |
| Mar 31, 2021 | -31.38% |